» Articles » PMID: 22923402

Evidence of in Vivo Prophage Induction During Clostridium Difficile Infection

Overview
Date 2012 Aug 28
PMID 22923402
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Prophages contribute to the evolution and virulence of most bacterial pathogens, but their role in Clostridium difficile is unclear. Here we describe the isolation of four Myoviridae phages, ΦMMP01, ΦMMP02, ΦMMP03, and ΦMMP04, that were recovered as free viral particles in the filter-sterilized stool supernatants of patients suffering from C. difficile infection (CDI). Furthermore, identical prophages were found in the chromosomes of C. difficile isolated from the corresponding fecal samples. We therefore provide, for the first time, evidence of in vivo prophage induction during CDI. We completely sequenced the genomes of ΦMMP02 and ΦMMP04, and bioinformatics analyses did not reveal the presence of virulence factors but underlined the unique character of ΦMMP04. We also studied the mobility of ΦMMP02 and ΦMMP04 prophages in vitro. Both prophages were spontaneously induced, with 4 to 5 log PFU/ml detected in the culture supernatants of the corresponding lysogens. When lysogens were grown in the presence of subinhibitory concentrations of ciprofloxacin, moxifloxacin, levofloxacin, or mitomycin C, the phage titers further increased, reaching 8 to 9 log PFU/ml in the case of ΦMMP04. In summary, our study highlights the extensive genetic diversity and mobility of C. difficile prophages. Moreover, antibiotics known to represent risk factors for CDI, such as quinolones, can stimulate prophage mobility in vitro and probably in vivo as well, which underscores their potential impact on phage-mediated horizontal gene transfer events and the evolution of C. difficile.

Citing Articles

Removal of mobile genetic elements from the genome of and the implications for the organism's biology.

Hussain H, Nubgan A, Rodriguez C, Imwattana K, Knight D, Parthala V Front Microbiol. 2024; 15:1416665.

PMID: 38966395 PMC: 11222575. DOI: 10.3389/fmicb.2024.1416665.


Insight into the Mechanism of Lysogeny Control of phiCDKH01 Bacteriophage Infecting Clinical Isolate of .

Iwanicki A, Roskwitalska M, Frankowska N, Wultanska D, Kabala M, Pituch H Int J Mol Sci. 2024; 25(11).

PMID: 38891850 PMC: 11172241. DOI: 10.3390/ijms25115662.


Transcriptomic and proteomic analysis of the virulence inducing effect of ciprofloxacin on enterohemorrhagic Escherichia coli.

Kijewski A, Witso I, Sundaram A, Brynildsrud O, Pettersen K, Anonsen E PLoS One. 2024; 19(5):e0298746.

PMID: 38787890 PMC: 11125564. DOI: 10.1371/journal.pone.0298746.


Novel insights into phage biology of the pathogen based on the active virome.

Schuler M, Daniel R, Poehlein A Front Microbiol. 2024; 15:1374708.

PMID: 38577680 PMC: 10993401. DOI: 10.3389/fmicb.2024.1374708.


Novel ribotype/sequence type associations and diverse CRISPR-Cas systems in environmental Clostridioides difficile strains from northern Iraq.

Rashid S, Nale J, Millard A, Clokie M FEMS Microbiol Lett. 2023; 370.

PMID: 37723612 PMC: 10806358. DOI: 10.1093/femsle/fnad091.


References
1.
Shan J, Patel K, Hickenbotham P, Nale J, Hargreaves K, Clokie M . Prophage carriage and diversity within clinically relevant strains of Clostridium difficile. Appl Environ Microbiol. 2012; 78(17):6027-34. PMC: 3416593. DOI: 10.1128/AEM.01311-12. View

2.
Lyras D, OConnor J, Howarth P, Sambol S, Carter G, Phumoonna T . Toxin B is essential for virulence of Clostridium difficile. Nature. 2009; 458(7242):1176-9. PMC: 2679968. DOI: 10.1038/nature07822. View

3.
Mahony D, Bell P, EASTERBROOK K . Two bacteriophages of Clostridium difficile. J Clin Microbiol. 1985; 21(2):251-4. PMC: 271625. DOI: 10.1128/jcm.21.2.251-254.1985. View

4.
Leplae R, Hebrant A, Wodak S, Toussaint A . ACLAME: a CLAssification of Mobile genetic Elements. Nucleic Acids Res. 2003; 32(Database issue):D45-9. PMC: 308818. DOI: 10.1093/nar/gkh084. View

5.
Broudy T, Fischetti V . In vivo lysogenic conversion of Tox(-) Streptococcus pyogenes to Tox(+) with Lysogenic Streptococci or free phage. Infect Immun. 2003; 71(7):3782-6. PMC: 161974. DOI: 10.1128/IAI.71.7.3782-3786.2003. View